Iovance Biotherapeutics
More roles at Iovance BiotherapeuticsSenior Director, Program Team Lead
Remote role where the employee must remain based in a particular country.
Listed for United States
Source: the job board's country tag. The advert itself does not name United States.
Employer listed it 4 weeks ago · Added 3 weeks ago
Been open since 4 weeks ago, still being checked, but it has been live a while.
Salary
$270,000 to $290,000
Location
Listed for United States
Timezone
Not stated
Contract
Full-time
Experience
Lead
Category
Other
Stated by the employer in the job description
What the advert says
Quoted word for word from the employer's advert. Where it says nothing, we say so.
- Working hours
- Not mentioned in the advert
- Where you can work from
As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is…
- Contract
- Not mentioned in the advert
- Experience asked for
- Not mentioned in the advert
- Pay
The annual base salary we reasonably expect to pay is listed.
Remote flexibility
Work from home
This is a remote role, but the employee must be based in United States. It is work from home rather than work from anywhere.
What the employer says
- Source listing states candidate location: "Remote, US-Remote"
- Job description states: "U.S.-based"
What Nomaders makes of it
- Payroll and tax are likely handled in that country only
The quotes above are the employer's own words; the reading is ours. Always check the original listing and employment terms before working from another country.
Before you apply
Questions worth asking: Nomaders interpretation
- The advert does not say whether this is employment or a contractor arrangement. Ask, as it affects tax and benefits.
Produced automatically from this advert's text; not reviewed by a person. The employer's own page is the final word.
About the role
About Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The Iovance TIL platform spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit www.iovance.com .
Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners.
Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on www.iovance.com .
Overview
The Senior Director, Program Team Lead owns integrated program strategy for one or more TIL cell therapy assets across early-to-late-stage clinical development. This role connects clinical, CMC, regulatory, and commercial workstreams into a single plan that maximizes clinical probability of success, regulatory approval, and commercial value, all within the context of Iovance's broader portfolio strategy.
The Program Team Lead chairs the cross-functional program team, manages timelines across workstreams, and is the central point of accountability for translating strategy into execution. This individual partners with senior leadership to advance programs from early clinical studies through pivotal trials, global regulatory submissions, and into commercial planning.
The right candidate brings deep oncology development and CMC experience with the judgment to navigate autologous cell therapy. They are as comfortable shaping an early-stage data strategy as they are driving late-stage registration execution, and they ensure every program decision maintains a clear line of sight to clinical success, regulatory approval, and commercial differentiation.
Essential Functions and Responsibilities
Program Strategy
Own the program strategy and vision from early development through registration and commercialization, ensuring alignment with Iovance's TIL platform strategy.
Frame program decisions around clinical probability of success, regulatory path, and commercial value.
Develop and present strategic options and trade-off analyses to senior leadership and governance bodies.
Track the competitive landscape in solid tumor oncology and cell therapy; translate insights into program-level actions.
Cross-Functional Execution
Work to align SME deliverables with overall development strategy, anticipating risks, proposing alternative scenarios and working with the cross functional team to drive accountability.
Partner with the Program Manager to align domain area strategy & execution plans with asset level strategy across all functions, including Clinical, Regulatory, Commercial and CMC.
Own program dashboards/reporting that keeps leadership informed on program status, timelines, strategic roadmap progress, upcoming inflection points, and open risks.
Governance and Stakeholder Management
Serve as the primary strategic voice for assigned programs in governance forums and executive reviews.
Proactive escalation & driving of resolution recommendations with senior leadership.
Support due diligence, business development, and investor-related activities for assigned programs.
Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics.
Perform miscellaneous duties as assigned.
Requirements
- ·Advanced degree (PhD, PharmD, MD, MBA, or equivalent).
- ·11+ years in clinical drug development with strong CMC experience in oncology, in particular experience with CGT, especially CAR-T, viral, TIL and other products with.
- ·Working knowledge of the global clinical and commercial landscape in oncology and cell therapy.
- ·Strong strategic and analytical skills — able to synthesize inputs from clinical, regulatory, commercial, and CMC functions into clear recommendations.
- ·Track record leading cross-functional teams through multiple development phases, including regulatory submissions and health authority interactions.
Benefits
No benefits package published with this listing. Ask about it at first interview.
How to apply
- 1Check the flexibility label above, work from home, matches where you plan to live and work.
- 2Tailor your CV to the role at Iovance Biotherapeutics, mentioning your remote working experience.
- 3Apply directly on the employer's careers page using the button below. Nomaders never handles your application.
Found 25d ago. Last checked 17 Nov. Always confirm the details on the original posting, salary and location can change after publication.
Listing sourced from Company boards.
$270,000 to $290,000 · You'll be taken to the employer's careers page.